| mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
-0.014 |
0.9 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
Bryostatin 1 |
FIMM |
pan-cancer |
AAC |
0.012 |
0.9 |